Argorna Pharmaceuticals Co., LTD SARS-CoV-2 mRNA vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Argorna Pharmaceuticals Co., LTD SARS-CoV-2 mRNA vaccine, covering 2024-01-10 to 2024-01-10. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults [Phase 1, Phase 2]